TrovaGene Inc (NASDAQ: TROV) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced updated results following a presentation at AACR. As you could imagine, the positive data excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The … Read more
Amarin Corporation plc (NASDAQ: AMRN) has been receiving quite a bit of attention among investors, and for good reason. The company has quite a bit coming up and is becoming one heck of a takeover target. I published a detailed look at the company on one of the new CNA Finance Brands, Alpha Stock News. … Read more
Recro Pharma Inc (NASDAQ: REPH) is having a great day in the market today, and for good reason. The company announced that it is restructuring its Acute Care Segment. As you could imagine, the restructuring news excited investors, sending the stock screaming for the top. Today, we’ll talk about: The restructuring news; what we’re seeing … Read more
Aptinyx Inc (NASDAQ: APTX) is headed for the top in the market this morning, and for good reason. The company announced positive preclinical data, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The positive data; what we’re seeing from APTX stock as a result; and what we’ll … Read more
Precipio Inc (NASDAQ: PRPO) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that its product has been adopted by a new hospital. Of course, the news excited investors who are pushing the stock for the top. Today, we’ll talk about: The new customer adoption; … Read more
Bio-Path Holdings Inc (NASDAQ: BPTH) is having a great start to the trading session in the pre-market hours this morning, and for good reason. The company presented positive pre-clinical data, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The data presentation; what we’re seeing from BPTH stock as a … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) is making a run for the top in the market this morning, and for good reason. The company announced data from a Phase 1/2 trial that it is working on with Pfizer (PFE). The data release proved to be positive, exciting investors and sending the stock screaming for the top. … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is making a run for the top in the market this morning. However, if you’re looking for press releases or SEC filings that may be the reason for the gains, you may find yourself upset. There’s nothing out there. Nonetheless, there is a good reason for the movement. Today, we’ll … Read more
TG Therapeutics Inc (NASDAQ: TGTX) is making a run for the top in the market this morning, and for good reason. The company released interim data from a Phase 2b clinical trial. As you could imagine, the news was positive, exciting investors and sending the stock on a run for the top. Today, we’ll talk … Read more
Pulmatrix Inc (NASDAQ: PULM) is making a run for the top in the market this morning, and for good reason. The company announced that it has entered into a Binding Term Sheet, exciting investors and sending the stock toward the top. Today, we’ll talk about: The term sheet; what we’re seeing from PULM stock as … Read more